These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9886323)

  • 1. 'Low-risk' myelodysplastic syndrome is associated with excessive apoptosis and an increased ratio of pro- versus anti-apoptotic bcl-2-related proteins.
    Parker JE; Fishlock KL; Mijovic A; Czepulkowski B; Pagliuca A; Mufti GJ
    Br J Haematol; 1998 Dec; 103(4):1075-82. PubMed ID: 9886323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS.
    Parker JE; Mufti GJ; Rasool F; Mijovic A; Devereux S; Pagliuca A
    Blood; 2000 Dec; 96(12):3932-8. PubMed ID: 11090080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of Fas, FasL and Bcl-2 and apoptosis of bone marrow CD34+ cells in patients with myelodysplastic syndrome].
    Zhang Z; Xie J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Jun; 11(3):274-7. PubMed ID: 12844412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More cell death in refractory anemia with excess blasts in transformation than in acute myeloid leukemia.
    Huh YO; Jilani I; Estey E; Giles F; Kantarjian H; Freireich E; Albitar M
    Leukemia; 2002 Nov; 16(11):2249-52. PubMed ID: 12399969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and prognostic significance of Bcl-2 family proteins in myelodysplastic syndromes.
    Boudard D; Vasselon C; Berthéas MF; Jaubert J; Mounier C; Reynaud J; Viallet A; Chautard S; Guyotat D; Campos L
    Am J Hematol; 2002 Jun; 70(2):115-25. PubMed ID: 12111784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDS and AML show elevated fractions of CD34-positive blast cell populations with a high anti-apoptotic versus proliferation ratio.
    Mestrum SGC; Roanalis BYV; de Wit NCJ; Drent RJM; Boonen BT; van Hemert WLW; Hopman AHN; Ramaekers FCS; Leers MPG
    Leuk Res; 2024 Jul; 142():107520. PubMed ID: 38776565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis, bcl-2 expression and p53 accumulation in myelodysplastic syndrome, myelodysplastic-syndrome-derived acute myelogenous leukemia and de novo acute myelogenous leukemia.
    Kurotaki H; Tsushima Y; Nagai K; Yagihashi S
    Acta Haematol; 2000; 102(3):115-23. PubMed ID: 10692673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells.
    Rajapaksa R; Ginzton N; Rott LS; Greenberg PL
    Blood; 1996 Dec; 88(11):4275-87. PubMed ID: 8943864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of apoptosis as a prognostic factor in myelodysplastic syndromes.
    Shimazaki K; Ohshima K; Suzumiya J; Kawasaki C; Kikuchi M
    Br J Haematol; 2000 Sep; 110(3):584-90. PubMed ID: 10997968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes.
    Bouscary D; De Vos J; Guesnu M; Jondeau K; Viguier F; Melle J; Picard F; Dreyfus F; Fontenay-Roupie M
    Leukemia; 1997 Jun; 11(6):839-45. PubMed ID: 9177438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes.
    Suárez L; Vidriales MB; García-Laraña J; Sanz G; Moreno MJ; López A; Barrena S; Martínez R; Tormo M; Palomera L; Lavilla E; López-Berges MC; de Santiago M; de Equiza ME; Miguel JF; Orfao A
    Clin Cancer Res; 2004 Nov; 10(22):7599-606. PubMed ID: 15569991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apparent expansion of CD34+ cells during the evolution of myelodysplastic syndromes to acute myeloid leukemia.
    Span LF; Dar SE; Shetty V; Mundle SD; Broady-Robinson L; Alvi S; Raymakers RA; de Witte T; Raza A
    Leukemia; 1998 Nov; 12(11):1685-95. PubMed ID: 9823942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bcl-2 expression by myeloid precursors in myelodysplastic syndromes: relation to disease progression.
    Davis RE; Greenberg PL
    Leuk Res; 1998 Sep; 22(9):767-77. PubMed ID: 9716007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptotic index by Annexin V flow cytometry: adjunct to morphologic and cytogenetic diagnosis of myelodysplastic syndromes.
    Merchant SH; Gonchoroff NJ; Hutchison RE
    Cytometry; 2001 Feb; 46(1):28-32. PubMed ID: 11241504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCL12+ stromal cells as bone marrow niche for CD34+ hematopoietic cells and their association with disease progression in myelodysplastic syndromes.
    Abe-Suzuki S; Kurata M; Abe S; Onishi I; Kirimura S; Nashimoto M; Murayama T; Hidaka M; Kitagawa M
    Lab Invest; 2014 Nov; 94(11):1212-23. PubMed ID: 25199050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anti-apoptotic genes Bcl-X(L) and Bcl-2 are over-expressed and contribute to chemoresistance of non-proliferating leukaemic CD34+ cells.
    Konopleva M; Zhao S; Hu W; Jiang S; Snell V; Weidner D; Jackson CE; Zhang X; Champlin R; Estey E; Reed JC; Andreeff M
    Br J Haematol; 2002 Aug; 118(2):521-34. PubMed ID: 12139741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased apoptosis in mononucleated cells but not in CD34+ cells in blastic forms of myelodysplastic syndromes.
    Berger G; Hunault-Berger M; Rachieru P; Fontenay-Roupie M; Baranger L; Ifrah N; Zandecki M
    Hematol J; 2001; 2(2):87-96. PubMed ID: 11424000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of CD34-positive cells in bone marrow from patients with myelodysplastic syndromes and acute myeloid leukemia and in normal individuals: a comparison between FACS analysis and immunohistochemistry.
    Kanter-Lewensohn L; Hellström-Lindberg E; Kock Y; Elmhorn-Rosenborg A; Ost A
    Eur J Haematol; 1996 Mar; 56(3):124-9. PubMed ID: 8598230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of all-trans retinoic acid on chemotherapy induced apoptosis and down-regulation of Bcl-2 in human myeloid leukaemia CD34 positive cells.
    Ahmed N; Laverick L; Sammons J; Baumforth KR; Hassan HT
    Leuk Res; 1999 Aug; 23(8):741-9. PubMed ID: 10456672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of p53, bcl-2 and ras oncoproteins and apoptosis levels in acute leukaemias and myelodysplastic syndromes.
    Invernizzi R; Pecci A; Bellotti L; Ascari E
    Leuk Lymphoma; 2001 Jul; 42(3):481-9. PubMed ID: 11699413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.